Applied Nutrition (APN) H1 2026 TU earnings summary

Executive summary

• Revenue for H1 FY26 reached £74.5 million, up 57% year-over-year from £47.6 million in H1 FY25.

• EBITDA for the period exceeded management expectations.

• Strong performance attributed to channel diversification and successful product launches.

Financial highlights

• H1 FY26 revenue: £74.5 million, a 57% increase compared to H1 FY25.

• Management expects full-year FY26 revenue of approximately £140 million.

• Consensus market expectations prior to this update were £133.5 million revenue and £37.7 million adjusted EBITDA for FY26.

Outlook and guidance

• FY26 results anticipated to be ahead of updated market consensus expectations.

• Revenue profile expected to be more H1-weighted than in prior years due to strong early demand.

• All FY26 figures remain subject to audit.